JPMorganEstimate Decrease, Recommendation Decrease
Fresenius Medical Care Transition year off a higher base, but still MSD cuts to FY26 EBIT. Lots of moving parts, further potential headwinds in FY27 and the parent overhang keeps us Underweight
分析师
Mr. David J. Adlington